GENERAL INCORPORATED ASS PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION has a total of 11 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are WIGEN BIOMEDICINE TECH SHANGHAI CO LTD, SHIN POONG PHARMACEUTICAL CO LTD and HUBEI BIO-PHARMACEUTICAL IND TECH INST INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Asai Akira | 11 |
#2 | Ogo Naohisa | 10 |
#3 | Muraoka Daisuke | 7 |
#4 | Harada Naozumi | 4 |
#5 | Shiku Hiroshi | 4 |
#6 | Sato Takuji | 3 |
#7 | Okawara Tadashi | 3 |
#8 | Akiyama Yasuto | 3 |
#9 | Kawabe Takumi | 3 |
#10 | Ashizawa Tadashi | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019078246A1 | Ido/tdo inhibitor | |
CN108697724A | Immunosupress agent for releasing and its utilization | |
AU2010339271A1 | 1,3,4-oxadiazole-2-carboxamide compound |